Tyrosine Administration Decreases Vulnerability to Ventricular Fibrillation in the Normal Canine Heart
- 13 February 1981
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 211 (4483) , 727-729
- https://doi.org/10.1126/science.7455710
Abstract
Intravenous infusion of tyrosine (1, 2, or 4 milligrams per kilogram) for 20 to 30 minutes caused dose-dependent increases in the ventricular fibrillation threshold in normal dogs. Administration of valine, a neutral amino acid that competes with tyrosine for uptake at the blood-brain barrier, in a dose equimolar to the most effective dose of tyrosine, slightly decreased the ventricular fibrillation threshold when given alone and significantly blocked elevation of the ventricular fibrillation threshold after tyrosine infusion. Hence, tyrosine, presumably acting in the central nervous system, can protect against certain ventricular arrhythmias.This publication has 25 references indexed in Scilit:
- Physiological control of brain norepinephrine synthesis by brain tyrosine concentrationLife Sciences, 1978
- Central neurochemical factors related to serotonin metabolism and cardiac ventricular vulnerability for repetitive electrical activityThe American Journal of Cardiology, 1978
- Mechanisms involved in the cardiovascular response to intracerebroventricular injection of noradrenaline and phentolamineNeuropharmacology, 1977
- Neural and psychologic mechanisms and the problem of sudden cardiac deathThe American Journal of Cardiology, 1977
- Muscarinic effects of vagosympathetic trunk stimulation on the repetitive extrasystole (RE) threshold.Circulation, 1976
- The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions.Circulation, 1975
- Kinetic analysis of blood-brain barrier transport of amino acidsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1975
- Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusionThe American Journal of Cardiology, 1975
- Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan and centrally administered 5-hydroxytryptamineNeuropharmacology, 1975
- Effect of digitalis on response of the ventricular pacemaker to sympathetic neural stimulation and to isoproterenolThe American Journal of Cardiology, 1974